INDEPENDENT DUAL RELEASE PHARMACEUTICAL COMPOSITION COMPRISING A PYRAZOLYL BENZENE SULFONIC ACID DERIVATIVE AND A CENTRAL ACTION OPIOID WITH MU RECEPTOR AFFINITY
The present invention relates to an independent dual release system comprising a pyrazolyl benzene sulfonic acid derivative, which is a COX-2 inhibitor and a centrally acting opioid with affinity to the mu receptor. The independent dual release system is formed by at least two matrices and is charac...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
08.10.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to an independent dual release system comprising a pyrazolyl benzene sulfonic acid derivative, which is a COX-2 inhibitor and a centrally acting opioid with affinity to the mu receptor. The independent dual release system is formed by at least two matrices and is characterized by providing a system of release of the assets in a specific way. Additionally, the system is useful for the treatment of moderate to severe pain.
La presente invención se refiere a un sistema de liberación dual independiente que comprende un derivado del ácido pirazolil bencensulfónico, el cual es un inhibidor de la COX-2 y un opioide de acción central con afinidad al receptor mu, el sistema de liberación dual independiente está formado por al menos dos matrices y se caracteriza por proporcionar un sistema de liberación de los activos de forma específica, además el sistema antes descrito es útil para el tratamiento del dolor moderado a severo. |
---|---|
Bibliography: | Application Number: MX20190008577 |